Last updated 53 days ago

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

48 patients around the world

Available in Peru, Brazil, United States

National Institute of Allergy and Infectious Diseases (NIAID)

4Research sites

48Patients around the world

Requirements for the patient

To 70 Years

All Gender

Medical requirements

Sites

Hospital Nossa Senhora da Conceição

Av. Francisco Trein, 596 – 2º andar - Bairro: Cristo Redentor - CEP 91350-200 - Porto Alegre

Instituto Nacional de Infectologia Evandro Chagas

Av. Brasil, 4365 - Manguinhos, Rio de Janeiro - RJ, 21040-360

Asociación Civil Impacta Salud y Educación - Barranco Clinical Research Site

Av. Almirante Miguel Grau 1010, Barranco, Lima 04

San Miguel CRS - Perú

Putumayo 177, San Miguel 15088, Peru

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)

Requirements

To 70 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05719441